<DOC>
	<DOCNO>NCT02282514</DOCNO>
	<brief_summary>Non-myeloablative regimen ( investigator use herein ) design maximally suppress immune system without destruction bone marrow stem cell compartment . When use non-myeloablative regimen recovery occur without infusion stem cell stem cell autologous . While necessary recovery , stem cell infusion may shorten interval neutropenia attendant complication . Thus reality transplant autologous supportive blood product . Based encouraging result non-myeloablative hematopoietic stem cell transplantation , patient multiple sclerosis chronic inflammatory demyelinate polyneuropathy , investigator investigate role non-myeloablative hematopoietic stem cell transplantation patient SPS require assistance ambulate .</brief_summary>
	<brief_title>Stem Cell Transplantation Stiff Person Syndrome ( SPS )</brief_title>
	<detailed_description>Pre-study Testing 1 . History physical ; 2 . Electrocardiogram ( EKG ) ; 3 . Dobutamine stress echocardiogram ; 4 . High-resolution compute tomography chest ( HRCT ) ; 5 . Blood draw laboratory tests- test include complete blood count , evaluate liver kidney function , assess immune system , tissue typing , check certain germ cause infection , include pregnancy test females prostate-specific antigen ( PSA ) male well test HIV ; 6 . Pulmonary Function Test ( PFT ) ; 7 . Electromyography ( EMG ) ; 8 . Magnetic Resonance Imaging ( MRI ) Abdomen Pelvis ; 9 . Magnetic Resonance Imaging ( MRI ) Spinal Cord ; 10 . Magnetic Resonance Imaging ( MRI ) Brain Gadolinium ( PERM cerebellar ataxia ) ; 11 . Colonoscopy ; 12 . Mammogram ( female ; 13 . Timed ambulation ; 14 . Quality Life Questionnaires [ Short Form ( 36 ) Health Survey ( SF36 ) Barthel Index ] ; 15 . Chronic Pain Acceptance Questionnaire ( CPAQ ) ; 16 . Rankin Functional Scale ; 17 . Modified Ashworth Scale ; 18 . PCA-1 , PCA-2 antibody ( cerebellar ataxia ) ; 19 . Spinocerebellar ataxia ( SCA ) 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 gene ( ataxia ) Study Treatment Stem Cell Collection-Cyclophosphamide 2.0 gm/m2 give day 0 , G-CSF 5-10 mcg/kg/day SQwill start day +5 continue apheresis discontinue . Apheresis begin ANC &gt; 1.0 x 109/L continue &gt; 2.0 x 106 CD34+ cells/kg patient weight cryopreserved . A 10-15 liter apheresis perform unless stop earlier clinical judgment toxicity ( e.g. , numbness , tetany ) . A maximum four apheresis perform . Conditioning regimen Cyclophosphamide 50 mg/kg/day give IV 1 hour 250 cc normal saline day -5 , -4 , -3 , -2 . If actual weight &lt; ideal weight , cyclophosphamide give base actual weight . If actual weight &gt; ideal weight , cyclophosphamide give adjusted ideal weight . Adjusted ideal weight = ideal weight + 40 % x actual weight minus ideal weight . Mesna 50mg/kg/day give IV 24 hour 250 cc normal saline D5W . Weight base calculate cyclophosphamide . ATG ( rabbit ) 0.5 mg/kg day -5 ; 1mg/kg day -4 -3 ; 1.5 mg/kg day -2 -1 ( total 5.5mg/kg , dose adjustment ) give IV 10 hour 250 cc normal saline begin least 1 hour infusion cyclophosphamide . Premedicate acetaminophen 650 mg po diphenhydramine 25 mg po/IV 30 minute infusion . An in-line 0.22 µm filter use ATG administration . Methylprednisolone A suggest dose 250mg IV administer 30 minute ATG infusion . Hydration A suggested rate 125 cc/hr NS give start 6 hour cyclophosphamide continue 24 hour last cyclophosphamide dose.The rate hydration aggressively adjust order avoid fluid overload . BID weight obtain . Amount fluid modify base patient 's fluid status . Minimum target urine output 2 liters/m2/day G-CSF 5 mcg/kg/day SQ continue absolute neutrophil count reach least 500/µl . Rituxan 500 mg give IV day first dose ATG day stem cell infusion .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Stiff-Person Syndrome</mesh_term>
	<criteria>1 . Diagnosis Stiffperson Syndrome Age 18 60 year old Failure medically tolerable dos ( 2040 mg/day ) diazepam Failure either IVIG plasmapheresis Stiffness axial muscle , prominently abdominal thoracolumbar paraspinal muscle lead fix deformity ( hyperlordosis ) Superimposed painful spasm precipitate unexpected noise , emotional stress , tactile stimulus Confirmation continuous motor unit activity agonist antagonist muscle electromyography diazepam antispasmatic medication Absence neurological cognitive impairment could explain stiffness Inability run walk , abnormal gait 2 . Diagnosis SPS variant— Progressive Encephalomyelitis Rigidity Myoclonus ( PERM ) define : Acute onset painful rigidity muscle spasm limbs trunk Brainstem dysfunction ( nystagmus , opsoclonus , ophthalmoparesis , deafness , dysarthria , dysphagia ) Profound autonomic disturbance . Positive serology GAD65 ( amphiphysin ) autoantibody , assess immunocytochemistry , western blot radioimmunoassay ( &gt; 1000 u/ml ) MRI may show increased signal intensity throughout spinal cord brainstem 3 . Diagnosis SPS variant antiGAD positive cerebellar ataxia Subacute chronic onset cerebellar symptoms—gait limb ataxia , dysarthria , nystagmus Positive serology GAD65 ( amphiphysin ) autoantibody , assess immunocytochemistry , western blot radioimmunoassay ( &gt; 1000 u/ml ) AntiGAD antibody cerebrospinal fluid Abnormal MRI image brainstem cerebellum cerebellar atrophy Negative history toxin alcohol Absence Vitamin B12 Vitamin E deficiency Absence positive HIV , syphilis whipple disease Absence consanguinity , positive family history ataxia positive genetic screen SCA1 , SCA2 , SCA3 , SCA6 , SCA 7 SCA8 mutation Current prior history malignancy paraneoplastic syndrome Inability sign understand consent compliant treatment Positive pregnancy test Inability comprehend irreversible sterility possible side effect Amphiphysin antibody positive LVEF &lt; 45 % ischemic coronary artery disease dobutamine stress echocardiogram DLCO &lt; 60 % predict Serum creatinine &gt; 2.0 mg/dl Bilirubin &gt; 2.0 mg/dl Platelet count &lt; 100,000 / ul , WBC &lt; 1,500 cells/mm3 History toxin alcohol abuse History Vitamin B12 Vitamin E deficiency Positive HIV , syphilis , whipple disease Consanguinity , positive family history ataxia positive genetic screen SCA1 , SCA2 , SCA3 , SCA6 , SCA 7 SCA8 mutation ( ataxia present ) Absence least one SPS associate antibody antiGAD , GABAA receptor associate protein , synaptophysin , gephyrin , GABAtransaminase</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>autoimmune disease</keyword>
	<keyword>stem cell</keyword>
	<keyword>autologous hematopoietic stem cell transplantation</keyword>
	<keyword>Stiff Person Syndrome ( SPS )</keyword>
</DOC>